Rankings
▼
Calendar
JAZZ FY 2020 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$12B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2.4B
+9.3% YoY
Gross Profit
$2.2B
93.7% margin
Operating Income
$378M
16.0% margin
Net Income
$239M
10.1% margin
EPS (Diluted)
$4.22
Cash Flow
Operating Cash Flow
$900M
Free Cash Flow
$520M
Stock-Based Comp.
$121M
Balance Sheet
Total Assets
$6.5B
Total Liabilities
$2.9B
Stockholders' Equity
$3.7B
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.4B
$2.2B
+9.3%
Gross Profit
$2.2B
$2.0B
+8.9%
Operating Income
$378M
$532M
-29.0%
Net Income
$239M
$523M
-54.4%
← Q4 2019
All Quarters
Q1 2020 →